Stock Markets April 29, 2026 02:23 AM

Fuchs posts Q1 results above forecasts, raises sales outlook for 2026

Company reports stronger margins and cash flow while nudging full-year sales guidance higher on inflationary effects

By Caleb Monroe
Fuchs posts Q1 results above forecasts, raises sales outlook for 2026

Fuchs SE reported first-quarter sales of €934 million and EBIT of €125 million, both ahead of analyst estimates. The company delivered organic growth across regions, expanded EBIT margins in EMEA and Asia-Pacific, and improved free cash flow and net liquidity. Management raised its full-year sales target to above €3.7 billion while keeping EBIT guidance at around €450 million and trimming the free cash flow expectation slightly below €270 million.

Key Points

  • Q1 sales €934 million and EBIT €125 million, both above consensus.
  • Organic growth in all regions, reported Americas sales lowered by FX effects.
  • Free cash flow improved to €54 million and net liquidity rose to €203 million.

Fuchs SE reported first-quarter results that outpaced analyst expectations, with sales of €934 million and earnings before interest and tax (EBIT) of €125 million for the three months ended March 31.

On a reported basis, sales rose 1.1% year-on-year and climbed 4.5% on an organic basis, topping the consensus sales estimate of €912.5 million. EBIT increased 15.7% compared with the prior-year quarter, beating the €112.4 million estimate and producing an EBIT margin of 13.3%, up from 11.7% in the first quarter of 2025.

Regional performance was mixed but broadly positive on an organic basis. EMEA delivered the strongest showing, with reported and organic sales of €547 million, an increase of 4.8% driven by higher volumes. Asia-Pacific generated €266 million in sales, up 0.8% reported and 6.4% organically, with contributions from China and Australia. Sales in North and South America came in at €172 million - a 6.0% decline on a reported basis but a 3.3% increase organically, with the reported decrease attributed to foreign exchange effects.

Profitability trends varied by region. EBIT margin in Asia-Pacific widened by 479 basis points, a figure that the company said was partially supported by a land sale in Australia. EMEA margin expanded by 137 basis points, reflecting the higher sales level there. By contrast, the margin in North and South America declined by 43 basis points.

Cash flow and liquidity improved noticeably. Free cash flow after acquisitions rose to €54 million, versus €3 million in the year-earlier quarter, a swing the company ascribed to solid earnings and active net working capital management. Net liquidity increased to €203 million from €151 million at the end of 2025.

Against that backdrop, Fuchs adjusted its full-year outlook for 2026. Management now expects sales to be significantly above €3.7 billion, citing inflation as the driver for the higher sales expectation compared with the prior €3.7 billion target. The company left its EBIT projection broadly unchanged at around €450 million. Free cash flow guidance was revised to be slightly below €270 million, down from the previous target of €270 million.


Key takeaways

  • Fuchs beat sales and EBIT estimates in Q1, delivering €934 million in sales and €125 million in EBIT, and improving its EBIT margin to 13.3%.
  • Regional organic growth was positive across EMEA, Asia-Pacific and the Americas, though reported sales in the Americas were lowered by foreign exchange effects.
  • Free cash flow and net liquidity strengthened, with free cash flow after acquisitions rising to €54 million and net liquidity to €203 million.

Risks and uncertainties

  • Foreign exchange movements materially affected reported sales in North and South America and remain a source of variability for reported results.
  • The company’s raised sales expectation for 2026 explicitly cites inflation as the reason for the higher target, indicating guidance is sensitive to inflation dynamics.
  • Portions of the margin improvement in Asia-Pacific were supported by a land sale in Australia, a transaction that may not recur and could affect comparability of margins.

Risks

  • Reported sales in the Americas were reduced by foreign exchange impacts, indicating FX exposure.
  • The upgraded full-year sales outlook depends on inflation, making guidance sensitive to price levels.
  • Asia-Pacific margin expansion was partly supported by a land sale in Australia, which may be non-recurring.

More from Stock Markets

Australian Shares Slip as Healthcare, Financials and Gold Weigh on Index Apr 29, 2026 Huhtamaki Tops Q1 Expectations but Flags Rising Polymer Costs as Margin Risk Apr 29, 2026 Kambi Holds FY26 EBITA Target Despite €4m Colombia Tax Hit Apr 29, 2026 Pernod Ricard Calls Off Merger Negotiations With Brown-Forman Apr 29, 2026 Symrise Q1 Sales Top Estimates; Company Sticks to Full-Year Targets Apr 29, 2026